{
  "response": {
    "text": "Based on the search results, specifically referencing the study \"Randomized Phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma\" (Cancer Invest. 2007 Apr-May;25(3):140-7), the second author is:\n\nSA: Teng-Hsu Wang\n",
    "citations": [
      "https://www.scielo.br/j/rbhh/a/bZGzJ3bzHY8FS7MZtLd7XkQ/?lang=en"
    ]
  }
}